Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
EurekAlert!13h
Promising ‘first’ in Alzheimer’s drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...
Lancaster Guardian1d
Lights, camera, action: Lancaster University graduate’s film achieves screen debut
A former Lancaster University student who was determined to be a film-maker has pushed boundaries and realised his ambition.
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
Researchers make breakthrough in Alzheimer's disease drug development
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.
Lancaster Guardian on MSN1d
Lancaster students up for national award
A group of Lancaster University engineering students has been shortlisted for a prestigious national award for their ...
New study is a promising ‘first’ in Alzheimer’s drug development
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...
Neuroscience News11h
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Concerns over solar farm plan near Lancaster University and West Coast Mainline
Lancaster City Council is behind the planning application to build solar panels and infrastructure on land south of Burrow ...